David Neafus

Interim CEO, CFO

Learn More About InterimExecs RED Team of Top Interim and Fractional CEOs, CFOs, COOs, CIOs and CMOs or Call Us at (847) 849-2800 

Neafus-238x300 (1)

David Neafus is an experienced finance executive with extensive experience in multiple industries including high-tech, bio-tech, manufacturing, distribution. Experienced in public equity offerings and private debt and equity offerings, M&A, turnarounds.


Company Stage Focus: Startup, Early Stage, Late Stage Venture Funded, Private Equity Backed, Turnaround/Distressed, IPO, Private

Interim CFO, Subcontract Manufacturer to the Networking Equipment Industry

Interim VP Finance, Pre-IPO Biotech Company


• Total funds raised for clients nearly $500 million
• Alnylam Pharmaceuticals IPO
• Sale of Glycofi to Merck for $400 million cash
• Sale of Stromedix to Biogen for $500+ million in total milestones
• Turnaround resulting in 50% revenue growth and profit increase of $2 million


• BSBA – Accounting, University of Minnesota
• MBA – Finance, Bentley College

Years Executive Experience: (15)
Years as an Interim Exec: (15)
Company Size: (<$100k-$200M)

• Audits
• Budget, Cost & Internal Controls
• Financial Analysis
• Debt Refinancing
• Board Advisory
• M&A – Acquisition Integration
• Turnaround – Distress
• Liquidation
• Crisis Management
• Turnaround – Corporate Finance

• Alternative Energy
• Biotechnology
• Business Services
• Life Sciences
• Management Consulting
• Manufacturing
• Medical Devices
• Packaging and Supply Chain
• Plastics
• Professional Services
• SaaS and Cloud Computing
• Wholesale/Distributors